αβ,α′β′-Diepoxyketones are mechanism-based inhibitors of nucleophilic cysteine enzymes

被引：2

作者：

de Munnik, Mariska ^{[1
,2
]}

Lithgow, Jasper ^{[1
,2
]}

Brewitz, Lennart ^{[1
,2
]}

Christensen, Kirsten E. ^{[3
]}

Bates, Robert H. ^{[4
]}

Rodriguez-Miquel, Beatriz ^{[4
]}

Schofield, Christopher J. ^{[1
,2
]}

机构：

[1] Univ Oxford, Dept Chem, Chem Res Lab, 12 Mansfield Rd, Oxford OX1 3TA, England

[2] Univ Oxford, Ineos Oxford Inst Antimicrobial Res, 12 Mansfield Rd, Oxford OX1 3TA, England

[3] Univ Oxford, Dept Chem, Chem Res Lab, Chem Crystallog, 12 Mansfield Rd, Oxford OX1 3TA, England

[4] GlaxoSmithKline, Tres Cantos Med Dev Campus, Calle Severo Ochoa 2, Madrid, Spain

来源：

CHEMICAL COMMUNICATIONS | 2023年 / 59卷 / 86期

关键词：

IRREVERSIBLE INHIBITORS; PROTEASOME INHIBITOR; BETA-LACTAMASE; INACTIVATION; LDT(MT2); BINDING; DISCOVERY; PROTEINS; REVEALS;

D O I：

10.1039/d3cc02932h

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

Epoxides are an established class of electrophilic alkylating agents that react with nucleophilic protein residues. We report alpha beta,alpha 'beta '-diepoxyketones (DEKs) as a new type of mechanism-based inhibitors of nucleophilic cysteine enzymes. Studies with the l,d-transpeptidase LdtMt2 from Mycobacterium tuberculosis and the main protease from SARS-CoV-2 (Mpro) reveal that following epoxide ring opening by a nucleophilic cysteine, further reactions can occur, leading to irreversible alkylation. alpha beta,alpha 'beta '-Diepoxyketones (DEKs) inhibit nucleophilic cysteine enzymes. DEKs react with a transpeptidase and the SARS-CoV-2 main protease via epoxide opening; retro-aldol and other reactions can then occur, enabling irreversible alkylation.

引用

页码：12859 / 12862

页数：4

共 50 条

[41] In vitro approaches to investigate mechanism-based inactivation of CYP enzymes
Polasek, Thomas M.
Miners, John O.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2007, 3 (03) : 321 - 329
[42] Mechanism-based probe for the analysis of cathepsin cysteine proteases in living cells
Hang, Howard C.
Loureiro, Joana
Spooner, Eric
van der Velden, Adrianus W. M.
Kim, You-Me
Pollington, Annette M.
Maehr, Rene
Starnbach, Michael N.
Ploegh, Hidde L.
ACS CHEMICAL BIOLOGY, 2006, 1 (11) : 713 - 723
[43] Mechanism-based approach towards cysteine protease inhibitor libraries.
Lee, A
Huang, L
Ellman, JA
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1999, 217 : U129 - U129
[44] Identification of potent and selective mechanism-based inhibitors of the cysteine protease cruzain using solid-phase parallel synthesis
Huang, L
Lee, A
Ellman, JA
JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (03) : 676 - 684
[45] The mechanism of cysteine oxygenation by cysteine dioxygenase enzymes
Aluri, Swathi
de Visser, Sam P.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2007, 129 (48) : 14846 - +
[46] The mechanism of cysteine oxygenation by cysteine dioxygenase enzymes
Aluri, Swathi
De, Visser, Sam P.
Journal of the American Chemical Society, 2007, 129 (48): : 14846 - 14847
[47] Neutrophil elastase inhibitors: recent advances in the development of mechanism-based and nonelectrophilic inhibitors
Sjo, Peter
FUTURE MEDICINAL CHEMISTRY, 2012, 4 (05) : 651 - 660
[48] Following the reactions of mechanism-based inhibitors with β-lactamase by Raman crystallography
Helfand, MS
Totir, MA
Carey, MP
Hujer, AM
Bonomo, RA
Carey, PR
BIOCHEMISTRY, 2003, 42 (46) : 13386 - 13392
[49] SYNTHESIS AND EVALUATION OF A NEW SERIES OF MECHANISM-BASED AROMATASE INHIBITORS
LESUISSE, D
GOURVEST, JF
HARTMANN, C
TRIC, B
BENSLIMANE, O
PHILIBERT, D
VEVERT, JP
JOURNAL OF MEDICINAL CHEMISTRY, 1992, 35 (09) : 1588 - 1597
[50] MECHANISM-BASED INHIBITORS AND ALTERNATE SUBSTRATES OF GLYOXALASE-I
JORDAN, F
HALL, SS
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1982, 184 (SEP): : 77 - BIOL

← 1 2 3 4 5 →